Cooper Companies vs Dr. Reddy's Laboratories
Cooper Companies (COO), health care, and Dr. Reddy's Laboratories (RDY), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Dr. Reddy's Laboratories is worth $12.3B on the stock market and Cooper Companies $11.5B: Dr. Reddy's Laboratories is valued at 7% more. Cooper Companies trades at 20.9 times earnings and Dr. Reddy's Laboratories at 41.1; operating margins in their latest fiscal years were 16.7% and 15.0%. Over the past year Cooper Companies's share price has moved -14.3% and Dr. Reddy's Laboratories's +4.85%.
Key facts
- Cooper Companies market value
- $11.5B
- Dr. Reddy's Laboratories market value
- $12.3B
- Cooper Companies P/E
- 20.9
- Dr. Reddy's Laboratories P/E
- 41.1
- Cooper Companies revenue
- $4.1BFY to 2025-10-31
- Dr. Reddy's Laboratories revenue
- $3.6BFY to 2026-03-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Cooper Companies | Dr. Reddy's Laboratories |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-10-31 | 2026-03-31 |
| Size | ||
| Market cap | $11.5Blower | $12.3Bhigher |
| Revenue | $4.1Bhigher | $3.6Blower |
| Earnings | $374.9Mlower | $456Mhigher |
| Employees | 15,000lower | 27,527higher |
| Total assets | $12.4Bhigher | $6.2Blower |
| Valuation | ||
| P/E | 20.9lower | 41.1higher |
| P/S | 2.8lower | 3.4higher |
| P/B | 1.4 | — |
| Dividend yield | 0.00% | — |
| Profitability | ||
| Operating margin | 16.7%higher | 15.0%lower |
| Balance sheet | ||
| Net assets | $8.2Bhigher | $4Blower |
| Total liabilities | $4.2Bhigher | $2.1Blower |
| Total debt | $2.5Bhigher | $193.7Mlower |
| Cash on hand | $110.6Mlower | $163.5Mhigher |
| Price change | ||
| Today | -1.87%lower | +0.61%higher |
| 1 year | -14.3%lower | +4.85%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Cooper Companies only (7)
- Barry Rosenstein13.7%
- Glenn Greenberg4.9%
- Mark Boyar1.2%
- Diamond Hill team0.4%
- Brandon Haley0.2%
- Ken Griffin0.2%
- Bill Nygren0.1%
Dr. Reddy's Laboratories only (0)
None of the tracked investors.
Percentages are each holding's share of that investor's reported portfolio. Who owns COO · Who owns RDY
More on Cooper Companies
Further comparisons
Cooper Companies against its closest peers
Dr. Reddy's Laboratories against its closest peers
Learn
Questions and answers
Which is bigger, Cooper Companies or Dr. Reddy's Laboratories?
By market value, Dr. Reddy's Laboratories is the larger: $12.3B against $11.5B for Cooper Companies. By revenue in its latest fiscal year, Cooper Companies is the larger: $4.1B against $3.6B for Dr. Reddy's Laboratories.
Which has the higher P/E ratio?
Dr. Reddy's Laboratories: 41.1, against 20.9 for Cooper Companies. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Cooper Companies: 16.7%, against 15.0% for Dr. Reddy's Laboratories. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has more debt?
Cooper Companies: $2.5B, against $193.7M for Dr. Reddy's Laboratories. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Cooper Companies and Dr. Reddy's Laboratories?
None of the tracked superinvestors holds both in their latest 13F filing. 7 hold Cooper Companies and 0 hold Dr. Reddy's Laboratories.
Cite this page
Funkfolio, “Cooper Companies vs Dr. Reddy's Laboratories”, data as of 18 November 2026. https://funkfolio.com/compare/coo-vs-rdy
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.